POINT Biopharma Global
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $98,293,213 and profit margin reached 43%. Total operating expenses were $101,057,268.
Profit Margin
| 2019 | 0 | -36.89K | |
|---|---|---|---|
| 2020 | 0 | -13.37M | |
| 2021 | 0 | -45.90M | |
| 2022 | 226.57M | 98.29M | 43.38% |
PNT Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 226.57M | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 226.57M | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 82.05M | 33.50M | 9.14M | 1.16K |
Selling and marketing | 0 | 0 | 0 | 7.23K |
Total operating expenses | 101.05M | 45.51M | 13.11M | 36.89K |
Operating income | 125.52M | -45.51M | -13.11M | -36.11K |
Other income (expenses), net | 4.06M | -84.99K | -170.31K | -780 |
Income before tax | 129.58M | -45.59M | -13.28M | -36.89K |
Income tax expense | 31.29M | 305.65K | 87.88K | -780 |
Net income | 98.29M | -45.90M | -13.37M | -36.89K |
Earnings per share | ||||
Basic EPS | 1.04 | -0.62 | -0.34 | 0 |
Diluted EPS | 1.02 | -0.62 | -0.34 | 0 |
| Data source | Data source | Data source |